Euroapi S.A.

Paris Stock Exchange EAPI.PA

Euroapi S.A. Price to Sales Ratio (P/S) on February 05, 2025: 0.28

Euroapi S.A. Price to Sales Ratio (P/S) is 0.28 on February 05, 2025, a -50.57% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Euroapi S.A. 52-week high Price to Sales Ratio (P/S) is 0.66 on February 26, 2024, which is 135.21% above the current Price to Sales Ratio (P/S).
Euroapi S.A. 52-week low Price to Sales Ratio (P/S) is 0.23 on March 21, 2024, which is -18.60% below the current Price to Sales Ratio (P/S).
Euroapi S.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.33.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Paris Stock Exchange: EAPI.PA

Euroapi S.A.

CEO	Mr. Ludwig De Mot
IPO Date	May 6, 2022
Location	France
Headquarters	15 Rue Traversiere
Employees	3,650
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Key trends

Past 5 years